Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DEA-HF: Comparison of Three Diuretic Regimens in Chronic Heart Failure
NCT05904808Phase 4Completed
- Sponsor
- Rambam Health Care Campus
- Start
- Apr 2023
- Primary completion
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of metolazone, acetazolamide in heart failure (HF), sponsored by Rambam Health Care Campus. Started Apr 2023; status: completed.
02
Drugs
metolazoneacetazolamide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT05904808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05904808.